Patent · US Active

Fast results hybrid capture assay and associated strategically truncated probes

US9376727B2 · kind B2 · utility

0Cited by
186References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2011
Grant dateJun 28, 2016
Priority date
Expiry dateFeb 23, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/708
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Strategically truncated probes specific for high-risk HPV nucleic acids, and methods for making and using the same, are disclosed herein. The disclosed probes, and methods of use thereof, permit fast and reliable detection of human papillomavirus in clinical samples without significant cross-reaction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.